Press "Enter" to skip to content

COVAXIN phase 2 trials to be held in September; GMCH to be one of the sites

India’s indigenously developed coronavirus vaccine, COVAXIN, has already shown successful results in phase 1 clinical trials. Now, for phase 2 clinical trials, Guwahati Medical College and Hospital (GMCH) has been chosen as one of the sites. Assam Health Minister Himanta Biswa Sarma on Friday has said that GMCH is set to be one of the centers for the phase 2 clinical trial of COVAXIN. 

Leave your comments

%d bloggers like this: